• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?

作者信息

Sawaki Masataka, Kataoka Ayumi

机构信息

Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.

出版信息

Ann Surg Oncol. 2023 Jun;30(6):3233-3234. doi: 10.1245/s10434-023-13206-y. Epub 2023 Feb 10.

DOI:10.1245/s10434-023-13206-y
PMID:36765007
Abstract
摘要

相似文献

1
ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?
Ann Surg Oncol. 2023 Jun;30(6):3233-3234. doi: 10.1245/s10434-023-13206-y. Epub 2023 Feb 10.
2
ASO Author Reflections: Bilateral Mastectomy After Neoadjuvant Therapy: An Ever-Increasing Trend?ASO作者反思：新辅助治疗后双侧乳房切除术：一种不断增加的趋势？
Ann Surg Oncol. 2018 Dec;25(Suppl 3):650-651. doi: 10.1245/s10434-018-6895-6. Epub 2018 Oct 16.
3
ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.ASO作者反思：新辅助化疗不影响乳腺癌手术后的短期结局。
Ann Surg Oncol. 2022 May;29(5):3011-3012. doi: 10.1245/s10434-021-11277-3. Epub 2022 Jan 7.
4
ASO Author Reflections: The Role of Imaging Modalities in Omitting Surgery in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.ASO作者反思：影像模态在接受新辅助化疗的乳腺癌患者中避免手术的作用。
Ann Surg Oncol. 2021 Nov;28(12):7430-7431. doi: 10.1245/s10434-021-10178-9. Epub 2021 May 22.
5
ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer.美国骨科学会作者反思：乳腺癌新辅助化疗后的结局及手术管理差异
Ann Surg Oncol. 2021 Oct;28(11):6498-6499. doi: 10.1245/s10434-021-09680-x. Epub 2021 Mar 3.
6
ASO Author Reflections: How Predictive Models Can Help Guide Axillary Surgery Decision Making After Neoadjuvant Chemotherapy.ASO作者反思：预测模型如何帮助指导新辅助化疗后腋窝手术的决策制定
Ann Surg Oncol. 2020 Dec;27(Suppl 3):690-691. doi: 10.1245/s10434-020-08933-5. Epub 2020 Jul 28.
7
ASO Author Reflections: The Pursuit of Eliminating Surgery after Neoadjuvant Systemic Therapy in Breast Cancer Patients.ASO作者反思：追求消除乳腺癌患者新辅助全身治疗后的手术
Ann Surg Oncol. 2021 Jun;28(6):3254-3255. doi: 10.1245/s10434-020-09324-6. Epub 2020 Dec 10.
8
ASO Author Reflections: The Case for Using Response to Neoadjuvant Chemotherapy to Guide Administration of Post-mastectomy Radiation.ASO作者反思：利用新辅助化疗反应指导乳房切除术后放疗的应用理由
Ann Surg Oncol. 2023 Oct;30(11):6516-6517. doi: 10.1245/s10434-023-13923-4. Epub 2023 Jul 26.
9
ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.ASO作者反思：新辅助内分泌治疗后乳腺癌腋窝手术的个体化选择
Ann Surg Oncol. 2021 Mar;28(3):1368-1369. doi: 10.1245/s10434-020-09435-0. Epub 2021 Jan 2.
10
ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?ASO作者反思：新辅助化疗后对淋巴结阳性乳腺癌进行前哨淋巴结手术：从肿瘤学角度看是否安全？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):707-708. doi: 10.1245/s10434-020-08954-0. Epub 2020 Jul 31.

本文引用的文献

1
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial.新辅助全身治疗中极少数有显著缓解的浸润性乳腺癌患者免除乳房切除术：一项多中心、单臂、2 期临床试验。
Lancet Oncol. 2022 Dec;23(12):1517-1524. doi: 10.1016/S1470-2045(22)00613-1. Epub 2022 Oct 25.
2
Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer.新辅助化疗后影像引导下乳腺活检预测残余癌的准确性。
JAMA Surg. 2020 Dec 1;155(12):e204103. doi: 10.1001/jamasurg.2020.4103. Epub 2020 Dec 16.
3
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.
新辅助全身治疗后消除乳腺癌手术模式：当前证据和未来挑战。
Ann Oncol. 2020 Jan;31(1):61-71. doi: 10.1016/j.annonc.2019.10.012.
4
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.新辅助全身治疗后可消除乳腺癌手术的例外响应者的临床可行性试验。
Ann Surg. 2018 May;267(5):946-951. doi: 10.1097/SLA.0000000000002313.
5
Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques.通过微创活检技术诊断乳腺癌新辅助化疗后的病理完全缓解
Br J Cancer. 2015 Dec 1;113(11):1565-70. doi: 10.1038/bjc.2015.381. Epub 2015 Nov 10.